FDA okayed a first-of-its-kind treatment for hairy cell leukemia (HCL).
Reminiscent of former Turing Pharmaceuticals CEO Martin Shrekli, a different pharma executive defended his company’s 400% price hike on an antibiotic.
FDA recently approved 2 new treatments, heightening competition in the HIV-1 drug marketplace.
FDA cleared the first and only easy-to-swallow liquid drug to treat amyotrophic lateral sclerosis (ALS).
A pharma maker is recalling one lot of an allergy medication because the bottles mistakenly contain this medication.
FDA is warning that a deadly infection has been reported with a widely-used class of diabetes drugs.
FDA recently approved a new treatment for 2 rare types of non-Hodgkin lymphomas, as well as a new drug to treat hereditary angiodema and 1 for Fabry disease. Here are the top three new drugs to treat rare diseases.
While FDA approved the first drug containing cannibidiol (CBD), it is cracking down on certain other CBD products marketed as supplements.
FDA clears first-of-its-kind gene therapy for rare disease.
While FDA approved the first generic version of epinephrine (EpiPen and EpiPen Jr, Mylan), the new product is not yet on the market.